Collegium Pharmaceutical Valuation Analysis Shows 81.6% Undervaluation

요약

“DCF analysis suggests Collegium Pharmaceutical is undervalued by 81.6% based on intrinsic value of $243.40 vs current price of $44.85”
“Company scores only 2/6 on valuation checks with P/E ratio of 24.26x above industry average of 19.86x”
“Analysis uses 2-stage Free Cash Flow to Equity model projecting $334.25M free cash flow by 2030”

Debt high Cash poor Valuation high Drawdown low Recent decline

콜리지엄 제약 기업 가치 분석, 81.6% 저평가 나타내
DCF 분석에 따르면 콜리지엄 제약의 내재가치는 243.40달러로, 현재 주가 44.85달러 대비 81.6% 저평가
기업 가치 평가에서 2/6점을 받았으며 P/E 비율은 24.26배로 업계 평균 19.86배를 상회
2단계 현금흐름 모델을 사용하여 2030년까지 3억3425만 달러의 자유현금흐름 예측

출처: simplywall.st
링크: https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-coll/collegium-pharmaceutical/news/is-collegium-pharmaceutical-coll-pricing-look-attractive-aft/amp

소셜 공유 미리보기(OG) 전용 페이지입니다.